483 Response Catalent Pharma Solutions Feb 2000

Yvonne Lozano FDA$119.00 - Available Now

FDA investigators audited the Catalent Pharma Solutions - Woodstock, IL, United States facility and issued inspectional observation (via FDA 483) on 01 Feb 2000.

Product details

  • Category:
  • Inspection end: 01 Feb 2000
  • Location: Woodstock, United States
  • FEI: 1419377
Add To Cart